X-Received: by 2002:a05:622a:14a:b0:318:d6a4:d106 with SMTP id v10-20020a05622a014a00b00318d6a4d106mr21620490qtw.567.1656877528885;
Sun, 03 Jul 2022 12:45:28 -0700 (PDT)
X-Received: by 2002:a05:6830:1dce:b0:618:d00f:a97e with SMTP id
a14-20020a0568301dce00b00618d00fa97emr5438400otj.250.1656877528579; Sun, 03
Jul 2022 12:45:28 -0700 (PDT)
Path: i2pn2.org!i2pn.org!usenet.blueworldhosting.com!feed1.usenet.blueworldhosting.com!peer02.iad!feed-me.highwinds-media.com!news.highwinds-media.com!news-out.google.com!nntp.google.com!postnews.google.com!google-groups.googlegroups.com!not-for-mail
Newsgroups: comp.protocols.dicom
Date: Sun, 3 Jul 2022 12:45:28 -0700 (PDT)
Injection-Info: google-groups.googlegroups.com; posting-host=155.94.216.100; posting-account=uMUGLQoAAAAoOKgG8uaQ7UiwufdxK7QN
NNTP-Posting-Host: 155.94.216.100
User-Agent: G2/1.0
MIME-Version: 1.0
Message-ID: <5b533646-23f1-4d06-9d08-47592e2ebd39n@googlegroups.com>
Subject: (PDF) Fragment-Based Drug Discovery by Steven Howard
From: hesterholt14@gmail.com (hester holt)
Injection-Date: Sun, 03 Jul 2022 19:45:28 +0000
Content-Type: text/plain; charset="UTF-8"
X-Received-Bytes: 1209